Search details
1.
Adjuvant Olaparib for Germline BRCA Carriers With HER2-Negative Early Breast Cancer: Evidence and Controversies.
Oncologist
; 28(7): 565-574, 2023 07 05.
Article
in English
| MEDLINE | ID: mdl-37210568
2.
Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception.
Breast Cancer Res Treat
; 200(1): 63-72, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-36856935
3.
Screening MRI Does Not Increase Cancer Detection or Result in an Earlier Stage at Diagnosis for Patients with High-Risk Breast Lesions: A Propensity Score Analysis.
Ann Surg Oncol
; 30(1): 68-77, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36171529
4.
Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristics.
Cancer
; 128(6): 1275-1283, 2022 03 15.
Article
in English
| MEDLINE | ID: mdl-34875721
5.
Cancer control in Latin America and the Caribbean: recent advances and opportunities to move forward.
Lancet Oncol
; 22(11): e474-e487, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34735817
6.
Are rare cancer survivors at elevated risk of subsequent new cancers?
BMC Cancer
; 19(1): 166, 2019 Feb 21.
Article
in English
| MEDLINE | ID: mdl-30791872
7.
Correction to: Pathogenic variants among females with breast cancer and a nonbreast cancer reveal opportunities for cancer interception.
Breast Cancer Res Treat
; 200(1): 73, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37178433
8.
ASO Visual Abstract: Screening MRI Does Not Increase Cancer Detection or Result in Earlier Stage at Diagnosis in Patients with High-Risk Breast Lesions-A Propensity Score Analysis.
Ann Surg Oncol
; 30(1): 78-79, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36222934
9.
Cervical cancer control in Latin America: A call to action.
Cancer
; 122(4): 502-14, 2016 Feb 15.
Article
in English
| MEDLINE | ID: mdl-26670695
10.
Use and Yield of Baseline Imaging and Laboratory Testing in Stage II Breast Cancer.
Oncologist
; 21(12): 1495-1501, 2016 12.
Article
in English
| MEDLINE | ID: mdl-27551013
11.
Systemic Therapies for Nonmetastatic Breast Cancer: The Role of Neoadjuvant and Adjuvant Chemotherapy and the Use of Endocrine Therapy.
Clin Obstet Gynecol
; 59(4): 756-771, 2016 12.
Article
in English
| MEDLINE | ID: mdl-27741213
12.
Progress and remaining challenges for cancer control in Latin America and the Caribbean.
Lancet Oncol
; 16(14): 1405-38, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-26522157
13.
Challenges to effective cancer control in China, India, and Russia.
Lancet Oncol
; 15(5): 489-538, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-24731404
14.
Older women's experience with breast cancer treatment decisions.
Breast Cancer Res Treat
; 145(1): 211-23, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24682710
15.
TP53-associated early breast cancer: new observations from a large cohort.
J Natl Cancer Inst
; 2024 Apr 03.
Article
in English
| MEDLINE | ID: mdl-38569880
16.
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancer.
NPJ Breast Cancer
; 10(1): 28, 2024 Apr 16.
Article
in English
| MEDLINE | ID: mdl-38627457
17.
Breast Cancer Screening in High-risk Women During Pregnancy and Lactation.
J Breast Imaging
; 5(5): 508-519, 2023 Sep 22.
Article
in English
| MEDLINE | ID: mdl-38416921
18.
Inequities in referrals to a breast cancer risk assessment and prevention clinic: a mixed methods study.
BMC Prim Care
; 24(1): 165, 2023 08 25.
Article
in English
| MEDLINE | ID: mdl-37626335
19.
Endometrial Cancer Risk Among Germline BRCA1/2 Pathogenic Variant Carriers: Review of Our Current Understanding and Next Steps.
JCO Precis Oncol
; 7: e2300290, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-38061009
20.
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.
Nat Commun
; 14(1): 7496, 2023 11 18.
Article
in English
| MEDLINE | ID: mdl-37980405